TCB-2
TCB-2 is a psychedelic drug that was first synthesized by Alexander Shulgin. It is a potent and selective partial agonist for the serotonin 5-HT2A receptor, and is thought to be a research chemical that has been sold online as a designer drug.
Chemistry[edit | edit source]
TCB-2 is a member of the 25-NB family. It is structurally related to 2C-B and DOB, with the 4-bromo group of 2C-B replaced by a 4-chloro group, and the 2,5-dimethoxy groups of DOB replaced by 2,5-dichloro groups.
Pharmacology[edit | edit source]
TCB-2 is a partial agonist at the 5-HT2A receptor. It has a high affinity for this receptor, with a Ki of 0.25 nM. This makes it around 6 times more potent than DOB, and slightly less potent than LSD.
Effects[edit | edit source]
The effects of TCB-2 are not well documented, as it is a relatively new substance. However, it is thought to produce effects similar to other psychedelic drugs, such as visual hallucinations, altered perception, and euphoria.
Legal Status[edit | edit source]
In the United States, TCB-2 is not specifically listed as a controlled substance, but it may be considered an analog of 2C-B or DOB, which are Schedule I drugs under the Controlled Substances Act.
See Also[edit | edit source]
References[edit | edit source]
TCB-2 Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD